Minamitani, M., S. Numajiri, and Y. Imada. 1982. Application of a live varicella vaccine to the immunosuppressive children and the incidence of a case of herpes zoster after vaccination. Acta Paediatrica Japonica (Overseas Edition) 24(1):175-179.

Nagel, M. A., R. Mahalingam, R. J. Cohrs, and D. Gilden. 2010. Virus vasculopathy and stroke: An under-recognized cause and treatment target. Infectious Disorders—Drug Targets 10(2):105-111.

Naruse, H., H. Miwata, T. Ozaki, Y. Asano, J. Namazue, and K. Yamanishi. 1993. Varicella infection complicated with meningitis after immunization. Acta Paediatrica Japonica 35(4):345-347.

Naseri, A., W. V. Good, and E. T. Cunningham, Jr. 2003. Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination. American Journal of Ophthalmology 135(3):415-417.

Ninane, J., D. Latinne, M. T. Heremans-Bracke, M. De Bruyere, and G. Cornu. 1985. Live varicella vaccine in severely immunodepressed children. Postgraduate Medical Journal 61(Suppl. 4):97-102.

Nunoue, T. 1984. Clinical observations on varicella-zoster vaccinees treated with immunosuppressants for a malignancy. Biken Journal 27(2-3):115-118.

Nyerges, G., Z. Meszner, E. Gyarmati, and S. Kerpelfronius. 1988. Acyclovir prevents dissemination of varicella in immunocompromised children. Journal of Infectious Diseases 157(2):309-313.

Oka, T., K. Iseki, R. Oka, S. Sakuma, H. Yoshioka, and M. Takahashi. 1984. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years. Biken Journal 27(2-3):103-109.

Ota, K., V. Kim, S. Lavi, E. L. Ford-Jones, G. Tipples, D. Scolnik, and R. Tellier. 2008. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old. Pediatric Infectious Disease Journal 27(9):847-848.

Otsuka, T., Y. Gomi, N. Inoue, and M. Uchiyama. 2009. Transmission of varicella vaccine virus, Japan. Emerging Infectious Diseases 15(10):1702-1703.

Ozaki, T., N. Nishimura, T. Muto, K. Sugata, S. Kawabe, K. Goto, K. Koyama, H. Fujita, Y. Takahashi, and M. Akiyama. 2005. Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan. Vaccine 23(10):1205-1208.

Pileggi, G. S., C. B. S. De Souza, and V. P. L. Ferriani. 2010. Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis Care and Research 62(7):1034-1039.

Preblud, S. R. 1986. Varicella—complications and costs. Pediatrics 78(4):728-735.

Prober, C. G., L. E. Kirk, and R. E. Keeney. 1982. Acyclovir therapy of chickenpox in immunosuppressed children—a collaborative study. Journal of Pediatrics 101(4):622-625.

Quinlivan, M., N. Sengupta, and J. Breuer. 2009. A case of varicella caused by co-infection with two different genotypes of varicelia-zoster virus. Journal of Clinical Virology 44(1): 66-69.

Ragozzino, M. W., L. J. Melton, L. T. Kurland, C. P. Chu, and H. O. Perry. 1982. Population-based study of herpes-zoster and its sequelae. Medicine 61(5):310-316.

Ross, A. H., E. Lenchner, and G. Reitman. 1962. Modification of chicken pox in family contacts by administration of gamma globulin. New England Journal of Medicine 267(8):369-376.

Sakaguchi, M., H. Miyazawa, and S. Inouye. 2000a. Sensitization to gelatin in children with systemic non-immediate-type reactions to varicella vaccines. Annals of Allergy, Asthma and Immunology 84(3):341-344.

Sakaguchi, M., T. Nakayama, H. Fujita, M. Toda, and S. Inouye. 2000b. Minimum estimated incidence in Japan of anaphylaxis to live virus vaccines including gelatin. Vaccine 19(4-5):431-436.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement